Cardio Flashcards

1
Q

Function of pulmonary artery catheter (3)

A

detect heart failure or sepsis, monitor therapy, and evaluate the effects of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Indications for Swan-Ganz (8 general)

A

Management of complicated myocardial infarction
Hypovolemia vs cardiogenic shock
Ventricular septal rupture (VSR) vs acute mitral regurgitation
Severe left ventricular failure
Right ventricular infarction
Unstable angina
Refractory ventricular tachycardia
Assessment of respiratory distress
Cardiogenic vs non-cardiogenic pulmonary edema
Primary vs secondary pulmonary hypertension
Assessment of type of shock
Assessment of therapy
Afterload reduction
Vasopressors
Beta blockers
Intra-aortic balloon counter-pulsation
Assessment of fluid requirement in critically ill patients
Hemorrhage
Sepsis
Acute renal failure aka Acute Kidney Injury
Burns
Management of postoperative open heart surgical patients
Assessment of valvular heart disease
Assessment of cardiac tamponade/constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

For which patients are you most likely checking K and Mg? (2) How frequently?

A

For patients at risk for arrythmias (post MI, low EF) and those being actively diuresed, you will likely be checking K and Mg twice daily.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Preferred method of repleting electrolytes? Which is not absorbed well PO?

A

If the patient has a central line, write “mix for central line”.
If they only have a peripheral, try to give replacement PO, but be cautious on an empty stomach. Magnesium is not absorbed well PO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rule to adjust electrolyte need for kidney fnc

A

The general rule of thumb is to divide the patient’s required electrolyte need by their creatinine (in mg/dL). For creat, 1 mg/dL = 88.4 uM
Example:
Patient’s K is 3.0 and Cr 141 –> 100 mEq*88.4/141 –> give the patient 60 mEq.

For decreased renal function:
Always error on the side of UNDER replacement. Calculate and round downward if indicated. Patients on hemodialysis should rarely require electrolyte repletion as they tend to increase. If dangerously low, be cautious in repletion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

K target for repletion

A

K (goal ≥ 4.0)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What dose of K gives what rise in plasma K?

A

Usually 10 mEq will give you a rise of 0.1 mEq/L

Examples:

  1. 0 – 100mEq
  2. 8 – 20mEq
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

K: difference between IV and PO administration

A

IV and PO have an equivalent effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fastest K infusion times (periph vs central line)

A

Fastest infusion time is 10 mEq/hr through a peripheral line, or 20 mEq/hr for a central line if on a monitored bed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mg target for repletion

A

Mg (goal ≥ 2.0)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What dose of Mg gives what rise in plasma Mg?

A

Usually 1 gm for each 0.1 mEq/L.

Examples:

  1. 6 – 4 gm IV
  2. 8 – 2gm IV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mg oral dose?

A

Magnesium oxide can be used PO (4 tabs being equal to 1 gm) but it is not absorbed well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Phosphate target for repletion

A

Phos (goal ≥ 3.0)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Formulations for phosphate replacement (2) and doses

A

KPhos or NaPhos.

> 2.0 – oral neutraphos 2 tabs po TID x 3 doses
1.5- 2.0 – 0.08 mmol/kg IV over 6 hrs
0-1.5 – 0.16 mmol/kg IV over 6 hrs

If the patient needs K as well, they will get 4.4 mEq of K for every 3 mmol of Kphos.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Phosphate replacement: be careful in the setting of ______

A

hypercalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Septal territory: Which leads and vessel(s)?

A

-Septal (V1, V2) - LAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anterior territory: Which leads and vessel(s)?

A

-Anterior (V3, V4) - LAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lateral territory: Which leads and vessel(s)?

A

-Lateral (V5,V6, I, aVL) - left circumflex territory or LAD (diagonal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Inferior territory: Which leads and vessel(s)?

A

-Inferior (II, III, aVF) - RCA (85%), Circumflex (15%), or sometimes wrap-around LAD; one hint is to look at lead I. If the ST segment is elevated it suggests circumflex, if the ST segment is depressed it suggests RCA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Posterior territory: Which leads and vessel(s)?

A

-Posterior (V1-V3) - high R, ST depression, and tall T waves in V1-V3 suggests infarct and not ischemia. Turn the ECG over and V1-V3 looks like an ST elevation. Will almost always have concurrent inferior infarct (II, III, aVF).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Absolute contraindications to ALL stress testing (6)

A

acute PE, MI within 48 hours, aortic dissection, uncontrolled BP (usually SBP >180), uncontrolled arrhythmias, uncontrolled CHF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Options to “stress” (3) and options for evaluating the heart’s response (3)

A

stress: treadmill, pharmacologic, and vasodilator
response: ECG, echo, nuclear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When to choose exercise stress test over others?

A

If patient can exercise and functional status is adequate (can walk two blocks without stopping), always choose exercise.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When to choose treadmill (ECG-monitored) exercise stress test versus other monitoring in exercise stress test? (6)

A

Does ECG show: LBBB, WPW, paced rhythm, on digoxin, major ST/TW changes at baseline, LVH?

  • If NO, exercise ECG (treadmill) test.
  • If YES, can choose exercise echo or exercise with nuclear imaging. These two have similar sensitivities/specificities, but stress echo is technically more difficult to organize and perform. For this reason nuclear stress tests are most commonly done under these circumstances.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

If patient cannot exercise, which stress test to do? (2)

A

Dobutamine (pharmacologic stress) + echo OR regadenoson (next generation adenosine - vasodilator) + nuclear.

Dobutamine is a positive inotrope with mainly β1 activity used to simulate exercise and increase myocardial workload. Regadenoson (Lexiscan) is a single bolus, selective adenosine receptor agonist (vasodilator stress) which vasodilates the coronary arteries, and must be combined with nuclear imaging.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Sequence in nuclear stress testing (3)

A
  1. Done with thallium injected at rest (thallium tends to distribute over a period of hours at rest)
  2. The stress portion is then performed (either exercise or regadenoson) and technecium (brand names Cardiolite (sestaMIBI) or Myoview (tersoriform)) is injected at the peak of stress (technecium is more specific in terms of its redistribution).
  3. Images are then taken during exercise (if done) with a gamma camera and at rest.
27
Q

So when you hear “I want a rest myoview”, the sequence is: _____ (3). “I want a stress thallium,” the sequence is: _____ (3).

A

“I want a rest myoview:” thallium at rest, regadenoson at rest, technecium at rest.

“I want a stress thallium:” thallium at rest, exercise, technicium at peak exercise.

28
Q

How to use nuclear stress testing to determine myocardial viability?

A

Nuclear stress testing can give you an idea of how much myocardial viability there is by reimaging typically 24 hours later. Based on the “washout” characteristics of the nuclear agent, one can determine whether viable tissue remains and whether the patient would benefit from revascularizaztion (PCI vs CABG).

29
Q

Interpreting nuclear stress tests

A

If perfusion is normal at rest and with stress, then the study is considered normal.

If perfusion is normal at rest but abnormal with stress, this is a reversible defect signifying ischemia.

If perfusion is abnormal during rest and stress, this is considered nonreversible and likely scar (old MI)

30
Q
  • SBP, DBP normal ranges

- MAP formula and normal range

A

Arterial Blood Pressure (BP):
Systolic (SBP) 90 - 140 mmHg
Diastolic (DBP) 60 - 90 mmHg

Mean Arterial Pressure (MAP) = SBP + (2 x DBP)/3
70 - 105 mmHg

31
Q
  • RAP normal range

- RVSP, RVDP normal ranges

A

Right Atrial Pressure (RAP) = Central venous pressure (CVP) 2 - 6 mmHg

Right Ventricular Pressure (RVP):
Systolic (RVSP) 15 - 25 mmHg
Diastolic (RVDP) 0 - 8 mmHg

32
Q
  • PASP, PADP normal ranges

- MPAP formula and normal range

A

Pulmonary Artery Pressure (PAP):
Systolic (PASP) 15 - 25 mmHg
Diastolic (PADP) 8 - 15 mmHg

Mean Pulmonary Artery Pressure (MPAP) = [PASP + (2 x PADP)]/3
10 - 20 mmHg

33
Q

PAWP normal range

A

Pulmonary Artery Wedge Pressure (PAWP) 6 - 12 mmHg

34
Q

LAP normal range

A

Left atrial pressure (LAP) 6 - 12 mmHg

35
Q
  • CO formula and normal range

- CI formula and normal range

A
Cardiac Output (CO) = HR x SV    
4.0 - 8.0 l/min

Cardiac Index (CI) = CO/BSA
2.5 - 4.0 l/min/m2
(goal is usually to keep above 2.0)

36
Q
  • SV formula and normal range

- SVI formula and normal range

A
Stroke Volume (SV) = CO/HR
60 - 100 ml/beat 	 

Stroke Volume Index (SVI) = CI/HR x 1000
33 - 47 ml/m2/beat

37
Q

Formula for estimating BSA

A

Body surface area (BSA) = sqrt(W x H) / 60

BSA is in m2, W is weight in kg, and H is height in cm

38
Q

SVR formula and normal range

A

Systemic Vascular Resistance (SVR) = 80 x (MAP - RAP)/CO
800 - 1200 dynes · sec/cm5
(goal for most CHF is 1000ish)

39
Q

PVR formula and normal range

A

Pulmonary Vascular Resistance (PVR) = 80 x (MPAP - PAWP)/CO
<250 dynes · sec/cm5
(or 150-300)

40
Q

CPP formula and normal range

A

Coronary Artery Perfusion Pressure (CPP) = Diastolic BP - PAWP
60 - 80 mmHg

41
Q

Formula and normal ranges for RVEDV, RVESV, RVEF

A

Right Ventricular End-Diastolic Volume (RVEDV) = SV/EF 100 - 160 ml

Right Ventricular End-Systolic Volume (RVESV) = EDV - SV
50 - 100 ml

Right Ventricular Ejection Fraction (RVEF) = SV/EDV
40 - 60%

42
Q

Normal ranges for PaO2, PaCO2, HCO3, pH, SaO2, SvO2

A

Partial Pressure of Arterial Oxygen (PaO2) 80 - 100 mmHg
Partial Pressure of Arterial CO2 (PaCO2) 35 - 45 mmHg
Bicarbonate (HCO3) 22 - 28 mEq/L
pH 7.38 - 7.42
Arterial Oxygen Saturation (SaO2) 95 - 100%
Mixed Venous Saturation (SvO2) 60 - 80%

43
Q

CaO2 formula and normal range

A

Arterial Oxygen Content (CaO2 in mL O2/L) = (1.38 mL O2/g)(Hgb in g/L)(SaO2 as a fraction) + (0.0304 mL O2/L/mmHg)(PaO2 in mmHg)
Normal 170-200 mL O2/L

For mL O2/dL:
CaO2 = (1.38 x Hgb (in g/dL) x SaO2) + (0.00304 x PaO2)
Normal 17 - 20 ml/dl

44
Q

CvO2 formula and normal range

A

Venous Oxygen Content (CvO2 in mL O2/L) = (1.38 mL O2/g)(Hgb in g/L)(SvO2 as a fraction) + (0.0304 mL O2/L/mmHg)(PvO2 in mmHg)
Normal 120-150 mL O2/L

For mL O2/dL:
CvO2 = (1.38 x Hgb (in g/dL) x SvO2) + (0.00304 x PvO2)
Normal 12 - 15 ml/dl

45
Q

C(a-v)O2 formula and normal range

A

A-V Oxygen Content Difference (C(a-v)O2) = CaO2 - CvO2
4 - 6 ml/dl
(40-60 mL O2 / L)

46
Q

DO2 formula and normal range

A
Oxygen Delivery (DO2 in mL O2/min) = CaO2 (mL O2/L) x CO (L/min)
Normal: 950-1150 mL O2/min

US units: (DO2 in mL O2/min) = CaO2 (mL O2/dL) x CO (L/min) x 10 dL/L

47
Q

VO2 formula and normal range

A

Oxygen Consumption (VO2) = (C(a - v)O2) in mL O2/L x CO in L/min

Normal 200 -250 mL O2/min

48
Q

O2ER formula and normal range

A

Oxygen Extraction Ratio (O2ER) = [(CaO2-CvO2)/CaO2] x 100%

Normal 22 - 30%

49
Q

After stent placement, make sure all pts are on ____ (2).

A

Ensure everyone is on high-dose ASA and plavix 75 following any stent placement. See above for duration of these agents.

50
Q

Indications for CABG: (3)

A
  • 3 vessel disease (left circumflex, right coronary, left anterior descending).
  • Left main coronary artery disease >50% (although stenting of the left main is becoming more common).
  • Diffuse disease (e.g. multiple plaques along the same artery) that is not amenable to stenting
51
Q

Vessels used for CABGs (2)

A

Saphenous vein
Internal mammary artery (internal thoracic artery)

Usually a saphenous vein graft (SVG) will not remain patent for as long a duration as left internal mammary artery grafts (LIMA) (aka left internal thoracic artery; often grafted to LAD) so LIMAs are preferred to SVG. You can identify a LIMA graft by the multiple staples seen along the left sternal border on a CXR.

52
Q

Types of stents (2) and medication requirements of each

A
  • Bare metal stent (BMS): requires ASA 325 for one month and then 81 mg for life, and plavix for 1 month to ideally 1 year. BMS are often placed because patient’s compliance and follow-up are questionable, and a drug-eluting stent requires longer plavix duration and noncompliance is much more dangerous.
  • Drug eluting stent (DES): sirolimus (Cypher or Nevo) requires 3 months of ASA 325 then 81 mg for life, and at least 1 year of plavix. Paclitaxel (Taxus) requires ASA 325 for 6 months then 81 mg for life, and at least 1 year of plavix.

Major drawback of BMS: in-stent restenosis; significantly reduced with DES, but at the cost of stent thrombosis if plavix is discontinued prematurely. A BMS is usually used in STEMIs because the patient’s compliance is unknown in acute setting.

53
Q

How long after stent placement can patient exercise?

A

After placement of stent, patients should not undergo vigorous exercise for first 3 weeks as the stent needs to endothelialize to prevent complications.

54
Q

Catheterizations: left heart (3-4 factors that can be assessed), right heart (2 factors that can be assessed)

A

Catheterizations can be left heart only (which includes coronary arteries +/- left ventriculogram done to assess wall motion, ejection fraction, and mitral regurg if present); right heart only (to assess hemodynamics +/- oxygenation levels); both right and left heart catheterization.

55
Q

Post-cath check: 5 steps

A
  • Checking the distal pulses bilaterally to ensure they’re equal.
  • Vital signs. The first sign of a bleeding complication such as a retroperitoneal bleed is hypotension, so in a hypotensive patient post cath bolus with IVF and call your fellow. Tachycardia may be pain induced and is a late sign of this complication.
  • Ask the patient about pain - ongoing chest pain is concerning - Get an ECG.
  • Check the femoral site for bleeding or hematomas. Ensure fem stop (pressure device applied to the arterial closure site) never remains in place over 6 hours (arterial thrombosis) - patient should lie flat an additional 6 hours after removal.
  • A hemoglobin and creatinine check 8 hours post-procedure. A slight bump in creatinine may occur, and don’t allow a drop in hemoglobin to scare you. The patient can be phlebotomized quite a bit in the cath lab (+ dilutional from periprocedural IVF), and a one to two unit drop can be expected. The goal is to ensure the hemoglobin level stabilizes, so base your suspicion of bleeding on the physical exam and clinical status of the patient, and keep checking hemoglobin levels Q6-Q8 to make sure it plateaus.
56
Q

Possible complications post-catheterization: (8)

A
  • Bleeding
  • Infection
  • AV fistula (pulsatile mass and systolic bruit) – order Doppler ultrasound of femoral artery is suspected.
  • Arterial thrombosis (cold extremity, loss of pulses)
  • Retroperitoneal hematoma (especially if back pain, hypotension, drop in hemoglobin) – order CT abdomen if suspected
  • Emboli (signs of CVA, big rise in creatinine, cold extremity)
  • Contrast-induced renal failure. Just watch and hydrate (usu. 3-5 days post-procedure)
  • Arrhythmias
  • Arterial dissection/stent thrombosis: chest pain post procedure.
57
Q

Cardiac veins (4)

A

great cardiac vein, the middle cardiac vein, the small cardiac vein and the anterior cardiac veins.

58
Q

Coronary artery dominance:

  • determined by?
  • prevalence of different types of dominance?
A

The artery that supplies the posterior descending artery (PDA) determines the coronary dominance.

  • Right-dominant if supplied by RCA
  • Left-dominant if supplied by CXA
  • Co-dominant if supplied by both RCA & CXA

Approximately 70% of the general population are right-dominant, 20% are co-dominant, and 10% are left-dominant.

(A precise anatomic definition of dominance would be the artery which gives off supply to the AV node i.e. the AV nodal artery. Most of the time this is the right coronary artery.)

59
Q

LCA supplies which regions? (3)

Main branches? (2)

A

Left side of the heart, the left atrium and ventricle, and the interventricular septum.

CXA & LAD

60
Q

RCA supplies which regions? (3)

Gives off which branch? (1)

A

Right atrium, portions of both ventricles, and the heart conduction system.

PAD (most often) which supplies the interventricular septum and portions of both ventricles.

61
Q

Indications for transesophageal ultrasound (4)

A
  • Infective endocarditis (if vegetation a not seen on transthoracic echo but suspicion is high, or with prosthetic valves
  • to r/o embolic source
  • acute dissection
  • mitral valve disease preoperatively
62
Q

DDx of heart failure with preserved LV ejection fraction

A

Diastolic heart failure (hypertensive heart disease, restrictive cardiomyopathy, hypertrophic cardiomyopathy, CAD, …) - incomplete (update from uptodate)

63
Q

RAD RALPH the LAD from VILLA

A

Right Axis Deviation:
RV hypertrophy
Anterolateral MI
Left Posterior Hemiblock

Left Axis Deviation:
Ventricular tachycardia
Inferior MI
LV hypertrophy
Left Anterior Hemiblock